Knowledge Hub

During a meningitis outbreak in Burkina Faso, families spent $90 on treatment, causing financial strain and loss of income

During a meningococcal meningitis epidemic in Burkina Faso, households spent, on average, US$90 for treatment and other direct costs for family members with the disease. These costs, the equivalent of one third of the country’s annual GDP per capita, were in addition to the loss of income and assets from family members caring for patients.

Full Citation:
Colombini A, Badolo O, Gessner BD et al.. 2011. Costs and impact of meningitis epidemics for the public health system of Burkina Faso. Vaccine. 29(33).

Title of Article: Costs and impact of meningitis epidemics for the public health system of Burkina Faso

Author(s): Colombini A, Badolo O, Gessner BD et al.

Publication Year: 2011

Publication Name: Vaccine

Publication Volume: 29(33)

Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/21641952

DOI (Digital Object Identifier): 10.1016/j.vaccine.2011.05.058

Topics: Economics & Return on Investment

Disease Vaccines: Meningococcal disease / MenACWY

Immunization Terms: Impoverishment

Countries: Burkina Faso

WHO Regions: Africa